Related Experiment Video

Updated: Feb 16, 2026

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.9K

Gemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) in Children

Anthony Pak-Yin Liu1, Alex Wing-Kwan Leung2, Daniel Ka-Leung Cheuk1

  • 1Department of Paediatrics and Adolescent Medicine Queen Mary Hospital.

Journal of Pediatric Hematology/Oncology
|December 15, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

724
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.9K

Related Experiment Videos

Last Updated: Feb 16, 2026

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.9K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

724
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.9K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K

Articles linked to this work by shared authors, journal, and citation graph.

Long-Term Remission in a Pediatric Patient With Therapy-Related Acute Myeloid Leukemia after Complementary Haplo-Cord Transplant with Vaccine Effect.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026

Does Staff Education Increase Sequential Compression Device Utilization: A Retrospective Study.

HCA healthcare journal of medicine·2026

Comparison of Resistive Index and Volume Flow in Ultrasound of Arteriovenous Fistula for Dialysis Access.

Hemodialysis international. International Symposium on Home Hemodialysis·2026

Translating transcriptomics analysis into diagnostic workflows: clinical variant identification and interpretation in hypothesis-driven and hypothesis-free approaches.

EBioMedicine·2026

Long-Term Kidney Outcomes in Paediatric Osteosarcoma Survivors: A 20-Year Multi-Centre Study.

Cancers·2026

Gestational Weight Gain and Its Association With Preeclampsia and Blood Pressure Trends: A Retrospective Cohort Study.

The Australian & New Zealand journal of obstetrics & gynaecology·2026

Evaluation for Nonaccidental Trauma and Bleeding Disorders in Infants Referred to Pediatric Hematology.

Journal of pediatric hematology/oncology·2026

BK Virus-Associated Hemorrhagic Cystitis in Nontransplanted Children With Hematological Malignancies: A Single-Center Case Series.

Journal of pediatric hematology/oncology·2026

A Novel Pathogenic Variant in RTEL1 Causes Dyskeratosis Congenita/Hoyeraal-Hreidarsson Syndrome: A Report of Two Cases.

Journal of pediatric hematology/oncology·2026

Application of Dual-Energy X-Ray Absorptiometry for Bone Mineral Density Screening in Pediatric, Adolescent, and Young Adult Cancer Survivors: A Multi-Institutional Study of 6 California Children's Hospitals.

Journal of pediatric hematology/oncology·2026

Hypofractionated Proton Beam Therapy for Localized Residual or Recurrent Unresectable Hepatoblastoma.

Journal of pediatric hematology/oncology·2026

Racial and Ethnic Disparities in Treatment Cost and Utilization in Pediatric and Young Adult Acute Lymphoblastic Leukemia.

Journal of pediatric hematology/oncology·2026

Review Article: Beyond the Therapeutic Ceiling in Inflammatory Bowel Disease-Mechanism-Based Positioning and Emerging Therapeutic Strategies.

Alimentary pharmacology & therapeutics·2026

Cytologic Sub-Categorization of Bethesda Category IV Nodules Has Significant Clinicopathologic Outcomes.

Cytopathology : official journal of the British Society for Clinical Cytology·2026

Efficient detection of human antigen-specific CD4+ T cells with peptide-exchangeable HLA-DP4 tetramers and multiplexed magnetic enrichment.

Journal of immunological methods·2026

Enhancing Tumor Immunogenicity through Hyaluronic Acid-Mediated Delivery of Nonself Antigenic Peptides.

ACS applied bio materials·2026

Outcomes of early amniotic membrane transplantation in acute ocular thermochemical injuries caused by carbide guns in India.

Indian journal of ophthalmology·2026

Diagnostic challenges posed by the wide morphological and immunophenotypic spectrum of plasma cell neoplasms.

Blood research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us